Invesco Pharmaceuticals ETF Rating $120.91 0.00 (0.00%) As of 07/2/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.67Holdings in PJP have an aggregate rating of Moderate Buy based on 406 analyst ratings issued in the past year covering 25 companies (92.4% of the portfolio).PJP Aggregate Price Target$120.91High Prediction$120.91Average Prediction$120.91Low Prediction$120.91Holdings in PJP have an aggregate price target of $120.91 and a range of $120.91 to $120.91 covering 25 companies (92.4% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PJP Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.64%ABBVAbbVie$260.88-0.1%4.0114 of 5 stars2.88$253.81 -2.7%25Analyst DowngradeAnalyst RevisionGap Down5.39%LLYEli Lilly and Company$1,208.37-0.5%4.2855 of 5 stars2.87$1,235.07 2.2%30Trending NewsAnalyst UpgradeAnalyst Revision5.25%JNJJohnson & Johnson$262.52-0.2%4.2635 of 5 stars2.74$256.70 -2.2%27Trending NewsGap Down5.16%ABTAbbott Laboratories$95.25-0.2%4.9931 of 5 stars2.89$118.42 24.3%27Analyst UpgradeGap Down5.10%MRKMerck & Co., Inc.$129.34-0.2%4.4725 of 5 stars2.70$131.83 1.9%20Positive NewsAnalyst ForecastAnalyst RevisionGap Down5.07%AMGNAmgen$374.153.9256 of 5 stars2.43$355.50 -5.0%30Positive NewsAnalyst ForecastGap Down4.54%GILDGilead Sciences$131.274.9691 of 5 stars2.86$158.41 20.7%29Positive NewsInsider TradeAnalyst RevisionGap Down4.46%PFEPfizer$24.29-0.1%4.5408 of 5 stars2.25$28.82 18.7%20Analyst DowngradeAnalyst Revision3.86%CORTCorcept Therapeutics$90.212.9154 of 5 stars2.75$88.83 -1.5%8News CoveragePositive News3.60%AMRXAmneal Pharmaceuticals$17.152.0412 of 5 stars2.71$15.80 -7.9%73.55%TVTXTravere Therapeutics$56.900.0%2.0881 of 5 stars2.69$52.08 -8.5%13News CoveragePositive News3.47%LQDALiquidia$78.933.1781 of 5 stars2.82$68.88 -12.7%113.45%LGNDLigand Pharmaceuticals$319.552.1979 of 5 stars2.88$257.71 -19.4%83.17%OCULOcular Therapeutix$9.643.0796 of 5 stars2.79$25.11 160.5%143.15%HRMYHarmony Biosciences$37.264.5525 of 5 stars2.27$41.44 11.2%11Positive NewsAnalyst Forecast2.99%BIIBBiogen$216.123.4703 of 5 stars2.52$217.41 0.6%312.89%COLLCollegium Pharmaceutical$37.033.4307 of 5 stars3.17$57.50 55.3%62.78%INVAInnoviva$22.313.639 of 5 stars2.57$36.20 62.3%72.77%ANIPANI Pharmaceuticals$86.034.2547 of 5 stars2.75$107.33 24.8%8News CoverageInsider TradeGap Down2.75%PBHPrestige Consumer Healthcare$49.38-0.1%4.1076 of 5 stars2.00$70.75 43.3%6News Coverage2.75%TARSTarsus Pharmaceuticals$65.442.89 of 5 stars2.78$90.67 38.5%9News CoverageHigh Trading Volume2.68%VTRSViatris$16.702.7908 of 5 stars2.57$17.50 4.8%72.66%REGNRegeneron Pharmaceuticals$654.274.8614 of 5 stars2.73$792.65 21.2%26Positive NewsAnalyst DowngradeGap Down2.65%BMYBristol Myers Squibb$58.05-0.1%4.5937 of 5 stars2.37$61.31 5.6%19Options VolumeAnalyst RevisionGap Down2.62%SUPNSupernus Pharmaceuticals$48.052.7343 of 5 stars2.43$62.17 29.4%7News CoverageAnalyst Upgrade This page (NYSEARCA:PJP) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
